IL-6 in inflammation, autoimmunity and cancer
T Hirano - International immunology, 2021 - academic.oup.com
IL-6 is involved both in immune responses and in inflammation, hematopoiesis, bone
metabolism and embryonic development. IL-6 plays roles in chronic inflammation (closely …
metabolism and embryonic development. IL-6 plays roles in chronic inflammation (closely …
Constitutive activation of STAT 3 in breast cancer cells: A review
K Banerjee, H Resat - International journal of cancer, 2016 - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in
numerous cancer types, including more than 40% of breast cancers. In contrast to tight …
numerous cancer types, including more than 40% of breast cancers. In contrast to tight …
[HTML][HTML] Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment
J López de Andrés, C Griñán-Lisón, G Jiménez… - Journal of hematology & …, 2020 - Springer
Cancer stem cells (CSCs) represent a tumor subpopulation responsible for tumor metastasis
and resistance to chemo-and radiotherapy, ultimately leading to tumor relapse. As a …
and resistance to chemo-and radiotherapy, ultimately leading to tumor relapse. As a …
Interleukin-6 signaling pathway in targeted therapy for cancer
Y Guo, F Xu, TJ Lu, Z Duan, Z Zhang - Cancer treatment reviews, 2012 - Elsevier
Interleukin-6 (IL-6) is a multifunctional cytokine which plays an important role in a wide
range of biologic activities in different types of cell including tumor cells. IL-6 is involved in …
range of biologic activities in different types of cell including tumor cells. IL-6 is involved in …
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis
Q Chang, E Bournazou, P Sansone, M Berishaj… - Neoplasia, 2013 - Elsevier
We have investigated the importance of interleukin-6 (IL-6) in promoting tumor growth and
metastasis. In human primary breast cancers, increased levels of IL-6 were found at the …
metastasis. In human primary breast cancers, increased levels of IL-6 were found at the …
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
M Garg, MK Shanmugam, V Bhardwaj… - Medicinal research …, 2021 - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3) is one of the crucial transcription
factors, responsible for regulating cellular proliferation, cellular differentiation, migration …
factors, responsible for regulating cellular proliferation, cellular differentiation, migration …
[HTML][HTML] Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population
Although inactivation of the PTEN gene has been implicated in the development of
resistance to the HER2 targeting antibody trastuzumab, the mechanisms mediating this …
resistance to the HER2 targeting antibody trastuzumab, the mechanisms mediating this …
Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8
ZC Hartman, GM Poage, P Den Hollander, A Tsimelzon… - Cancer research, 2013 - AACR
Triple-negative breast cancers (TNBC) are aggressive with no effective targeted therapies. A
combined database analysis identified 32 inflammation-related genes differentially …
combined database analysis identified 32 inflammation-related genes differentially …
[HTML][HTML] Resistance to trastuzumab
S Vivekanandhan, KL Knutson - Cancers, 2022 - mdpi.com
Simple Summary Trastuzumab is a humanized antibody that has significantly improved the
management and treatment outcomes of patients with cancers that overexpress HER2 …
management and treatment outcomes of patients with cancers that overexpress HER2 …
[HTML][HTML] Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3 …
SA Ibrahim, R Gadalla, EA El-Ghonaimy, O Samir… - Molecular cancer, 2017 - Springer
Background Inflammatory breast cancer (IBC), a particularly aggressive form of breast
cancer, is characterized by cancer stem cell (CSC) phenotype. Due to a lack of targeted …
cancer, is characterized by cancer stem cell (CSC) phenotype. Due to a lack of targeted …